Wei-Chiang Chen
Associate Director Sanofi
Wei Chiang is an Associate Director at Sanofi with over a decade of experience in analytical development and CMC operations for gene and cell therapy programs. Prior to Sanofi, he led analytical strategy and laboratory setup efforts at Flexion Therapeutics, Solid Biosciences, and Biogen, specializing in assay development, impurity profiling, and regulatory CMC submissions across multiple AAV platforms.
Seminars
Wednesday 25th February 2026
From Clinical Runs to Commercial Supply: Scaling AAV Production Without $3 Million Per Dose Costs
9:00 am
- Evaluating how early-stage manufacturing strategies for novel delivery platforms can be adapted for large-scale production without compromising quality or cost
- Exploring how automation, AI-driven design, modular unit operations, and raw material standardization can streamline process transfer and support scalable, reproducible manufacturing across diverse modalities
- Assessing technology transfer and process intensification approaches to enable costefficient, high-yield production for clinical and commercial supply
Wednesday 25th February 2026
Chair’s Opening Remarks
8:20 am
